Calidi Biotherapeutics, Inc. reported on August 8, 2025, the execution of a separation agreement with Dr. Boris Minev, following his departure as President of Medical and Scientific Affairs on July 29, 2025. The agreement includes a $100,000 bonus and $187,500 in separation pay over 6 months.